Asset Allocation

As of October 31, 2025.
Type % Net
Cash -0.00%
Stock 80.56%
Bond 8.07%
Convertible 0.00%
Preferred 0.20%
Other 11.17%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 83.65%
Mid 12.06%
Small 4.29%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 86.32%    % Emerging Markets: 1.09%    % Unidentified Markets: 12.59%

Americas 28.84%
28.50%
Canada 2.40%
United States 26.11%
0.33%
Mexico 0.19%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 47.55%
United Kingdom 11.47%
35.38%
France 13.33%
Germany 3.45%
Ireland 2.68%
Italy 5.40%
Netherlands 5.50%
Spain 2.90%
Switzerland 2.05%
0.51%
Turkey 0.51%
0.18%
Israel 0.11%
Nigeria 0.03%
United Arab Emirates 0.04%
Greater Asia 11.03%
Japan 0.00%
1.11%
Australia 1.11%
9.67%
Hong Kong 0.79%
Singapore 1.13%
South Korea 2.94%
Taiwan 4.82%
0.25%
India 0.20%
Unidentified Region 12.59%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
24.52%
Materials
2.06%
Consumer Discretionary
1.65%
Financials
20.81%
Real Estate
0.00%
Sensitive
44.89%
Communication Services
19.17%
Energy
6.87%
Industrials
4.29%
Information Technology
14.56%
Defensive
18.08%
Consumer Staples
3.44%
Health Care
6.61%
Utilities
8.03%
Not Classified
12.51%
Non Classified Equity
0.10%
Not Classified - Non Equity
12.41%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 3.92%
Corporate 53.79%
Securitized 35.46%
Municipal 0.00%
Other 6.83%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial